Labshake search
Citations for R&D Systems :
4651 - 4700 of 10000+ citations since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Developmental Biology 2022Quote: ... WNT3A (200 ng/ml; R&D systems, Minneapolis, MN), WNT5A (100 ng/ml ...
-
bioRxiv - Immunology 2022Quote: ... and IL-12 (R&D Systems #M1270) were determined in spinal cord supernatants 7- and 14-days post immunisation by ELISA ...
-
bioRxiv - Immunology 2022Quote: ... CD31 (rat polyclonal, R&D Systems, #AF3628, 1:100), peripheral node addressin (MECA-79 ...
-
bioRxiv - Immunology 2022Quote: Concentrations of mouse IL-23 (R&D Systems, #DY1887) and IL-12 (R&D Systems #M1270 ...
-
bioRxiv - Immunology 2022Quote: ... anti-ST6Gal1 antibody (R&D Systems) labelled with AF647 using a ThermoFisher Protein Labelling Kit (ThermoFisher ...
-
bioRxiv - Immunology 2022Quote: ... anti-CCR2 (clone 475301 in APC from R&D systems Cat# FAB5538A); anti-CX3CR1 (clone SA011F11 in BV786 from Biolegend Cat# 149029) ...
-
bioRxiv - Immunology 2022Quote: ... anti-CTLA-4 (clone 63828; R&D Systems) or with the respective isotype control ...
-
bioRxiv - Immunology 2022Quote: ... PE-conjugated anti-CTLA-4 and APC-conjugated anti-CD279 (PD-1) were purchased from R&D System (Minneapolis, MN). Human cytokines from cell culture supernatants were analyzed using ELISA kits for TNF ...
-
bioRxiv - Immunology 2022Quote: ... and TGFβ (R&D Systems, Minneapolis, MN). Anti-CTLA-4 neutralizing antibody and non-immune human IgG antibody were purchased from BPS Bioscience Inc (San Diego ...
-
bioRxiv - Immunology 2022Quote: ... Anti-IFN-α/β receptor (PBL Interferon Source) or control IgG2A antibody (R&D systems) were added at 1 μg/ml for 2 h before infection and supplemented every 4 days ...
-
bioRxiv - Immunology 2022Quote: ... and 100 ng/ml macrophage colony stimulating factor (R&D systems). For replication experiments with full-length viruses ...
-
bioRxiv - Immunology 2022Quote: ... 10 ng/mL IL-15 (R&D Systems), and 25 ng/mL mouse anti-human CD3 antibody (UCHT1 ...
-
bioRxiv - Immunology 2022Quote: ... 50 U/mL IL-2 (R&D Systems), 10 ng/mL IL-15 (R&D Systems) ...
-
bioRxiv - Immunology 2022Quote: Murine cytokine detection Duoset enzyme-linked immunosorbent assay (ELISA) kits were from R&D Systems (mIL-6, mTNF) or from Biolegends (mIL-10) ...
-
bioRxiv - Immunology 2022Quote: ... Autologous BCL were used as target cells and pre-incubated with 40 ng/mL IFN-γ (R&D System) for 18 hours at 37°C ...
-
bioRxiv - Immunology 2022Quote: ... CFSE-labelled cells were then resuspended in R10 media supplemented with recombinant IL-2 (R&D system) and 2-mercaptoethanol (Themo Fisher Scientific ...
-
bioRxiv - Immunology 2022Quote: ... for 18 hours at 37°C before supernatants where assessed for cytokine by ELISA (R&D systems).
-
bioRxiv - Immunology 2022Quote: ... After 18 hours media was harvested and investigated for expression of CCL20 by ELISA (R&D systems). Interleukin-2 expanded MAIT cells (1×106 ...
-
bioRxiv - Immunology 2022Quote: ... Media was harvested and investigated for expression of IL-17 by ELISA (R&D systems).
-
bioRxiv - Immunology 2022Quote: ... rhFGF (all from R&D Systems), and ROCK inhibitor (Y27632 ...
-
bioRxiv - Immunology 2022Quote: ... Tregs were polarized with 1 ng/mL of TGF-β1 (R&D Systems). Cells were cultured for 72 hours and collected for flow cytometry analysis.
-
bioRxiv - Immunology 2022Quote: ... anti-IL-10 (50 μg ml−1, clone JES052A5, R&D Systems) and stimulated with polyclonal anti-CD3 (1 μg ml−1 ...
-
bioRxiv - Immunology 2022Quote: ... human IL-6 ELISA kit (R&D Systems, D6050) and a human IL-8/CXCL8 ELISA kit (R&D Systems ...
-
bioRxiv - Immunology 2022Quote: ... PBMCs from healthy individuals were isolated and expanded in vitro for 7 days in the presence of 50 ng/ml of OKT-3 (Miltenyi) and 600 IU/ml IL-2 (R&D Systems) in AIM-V (Gibco ...
-
bioRxiv - Immunology 2022Quote: ... and stained with anti-IFN-γ (clone 25723, R&D Systems; 1:25) and anti-TNF-α (clone MAb11 ...
-
bioRxiv - Immunology 2022Quote: ... T cell lines were cultured for 10 days in the presence of 20 U/ml of recombinant IL-2 (R&D Systems).
-
bioRxiv - Immunology 2022Quote: ... in the presence of IL-2 (10 ng ml−1, R&D Systems), anti-IL-10 (50 μg ml−1 ...
-
bioRxiv - Immunology 2022Quote: ... and CCR7 PE (R&D systems). Clones of antibodies used in our study are detailed in Table 3 ...
-
bioRxiv - Immunology 2022Quote: Cytokine levels were measured with an ELISA assay according to the manufacturer’s protocol (R&D Systems, Minneapolis, MN). IL-1β ...
-
bioRxiv - Immunology 2022Quote: ... Goat IgG and IgA2 (R&D Systems). For inhibition of downstream signalling pathways molecules ...
-
bioRxiv - Immunology 2022Quote: ... IL1β (R&D systems, #AF-201), FLAG (SigmaAldrich ...
-
bioRxiv - Immunology 2022Quote: ... and a human IL-8/CXCL8 ELISA kit (R&D Systems, D8000C) was used.
-
bioRxiv - Immunology 2022Quote: ... NLRP1 (R&D systems, #AF6788), NLRP1 (Biolegend #9F9B12), ...
-
bioRxiv - Immunology 2022Quote: ... IL4 (10 ng/mL, M2-like, R&D Systems) or medium (M0 macrophages) ...
-
bioRxiv - Immunology 2022Quote: ... either alone or in combination with 1 μg/ml mouse IgG2 B anti-human TIGIT (R&D systems) or 1 μg/ml goat IgG anti-human TIM-3 (R&D systems ...
-
bioRxiv - Immunology 2022Quote: ... or 1 μg/ml goat IgG anti-human TIM-3 (R&D systems) and alone or in combination of 5 mM Metformin (SIGMA) ...
-
bioRxiv - Microbiology 2022Quote: ... IFN-β levels were determined using Mouse IFN-β DuoSet ELISA Kit (R&D systems). High-binding ELISA plates (Thermo Scientific ...
-
bioRxiv - Neuroscience 2022Quote: ... Non-specific blocking for 30 minutes in 8% horse serum in KPBS was completed before incubation in primary antibody (anti-HPLN1 1:150, R&D Systems 2608-HP) for 48 hours at 4°C ...
-
P2RX7 inhibition reduces breast cancer induced osteolytic lesions - implications for bone metastasisbioRxiv - Cancer Biology 2022Quote: ... caspase-3 (R&D Systems, AF835), Endomucin (Santa Cruz ...
-
P2RX7 inhibition reduces breast cancer induced osteolytic lesions - implications for bone metastasisbioRxiv - Cancer Biology 2022Quote: ... and 30ng/ml murine RANKL(R&D Systems, Abingdon, UK)) and were seeded onto dentine disks (generated in-house ...
-
P2RX7 inhibition reduces breast cancer induced osteolytic lesions - implications for bone metastasisbioRxiv - Cancer Biology 2022Quote: ... and 30ng/ml M-CSF (R&D Systems, Abingdon, UK) and incubated in T75 flasks for 24h at 37°C ...
-
bioRxiv - Biophysics 2022Quote: ... and human IL-13 (monoclonal capture antibody MAB213 and polyclonal detection antibody BAF213) were purchased from R&D Systems (Minneapolis, MN, USA).
-
bioRxiv - Cancer Biology 2022Quote: ... 50 μg of anti-XCL1 (R&D systems MAB486) or isotype-matched control antibodies (R&D systems MAB006 ...
-
bioRxiv - Cancer Biology 2022Quote: ... or isotype-matched control antibodies (R&D systems MAB006) were injected i.p ...
-
bioRxiv - Cancer Biology 2022Quote: CXCL10 ELISA (no. DIP100; R&D Systems) was used on media collected from cell culture according to manufacturer’s instructions ...
-
bioRxiv - Cancer Biology 2022Quote: ... Naïve CD8+ T cells were cultured in R10 media containing 5 ng/mL IL-7 (R&D systems). C57BL/6 CD8+ T cells were purified using the EasySep Mouse CD8 T Cell Isolation Kit (Stemcell technologies ...
-
bioRxiv - Cancer Biology 2022Quote: ... miniloci in an endogenous IgH and Igκ knockout background (19,20) were immunized with recombinant human LAG-3–Fc protein (hLAG-3–hFc) (R&D Systems, Minneapolis, MN, USA), consisting of the extracellular domain of LAG-3 (Leu23-Leu450 ...
-
bioRxiv - Biophysics 2022Quote: ... The medium was supplemented with 10 ng/ml recombinant mouse IL-2 (rmIL-2) (402-ML, R&D systems) for long-term culture of mouse ILC2s.
-
bioRxiv - Biophysics 2022Quote: ... and rhTSLP (1258-IL/CF, 3625-IL/CF, and 1398-TS/CF, R&D Systems).
-
bioRxiv - Cell Biology 2022Quote: ... αCCR7 blocking antibody (R&D systems, 2-5μg/ml), rat immunoglobulin (Ig ...